What top creators are saying about AbCellera Biologics Inc.(ABCL)

A technology company that searches and analyzes natural immune systems to find antibodies.

3 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about AbCellera Biologics Inc..

Mixed
avg +0.00
0 bullish1 neutral0 bearish

Top creators covering AbCellera Biologics Inc. (ABCL)

The 2 sources with the most insights about AbCellera Biologics Inc. on Kazuha.

Latest insights about AbCellera Biologics Inc. (ABCL)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Monday, August 31, 2026

Neutral

Has a market cap of $3.68B and 18.83% short interest as a percentage of float.

Monday, August 10, 2026

Very Bullish

Stock jumped over 30% to 37% following positive Phase 2 clinical trial results, providing a new valuation floor.

Monday, July 21, 2025

Neutral

Mentioned as one of the heavily shorted, smaller-cap stocks that saw significant gains due to a 'risk-on' appetite and speculative fervor in the market.

Discussed alongside AbCellera Biologics Inc. (ABCL)

Other assets that creators frequently mention in the same content as AbCellera Biologics Inc..

Frequently asked

Which podcasters and creators cover AbCellera Biologics Inc. (ABCL) the most?

The most active sources covering AbCellera Biologics Inc. (ABCL) on Kazuha are @amitinvesting, SgtWingflapper. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about AbCellera Biologics Inc. (ABCL) are on Kazuha?

Kazuha has indexed 3 AI-extracted insights about AbCellera Biologics Inc. (ABCL) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside AbCellera Biologics Inc. (ABCL)?

Creators covering AbCellera Biologics Inc. (ABCL) most frequently also discuss GOOGL, COIN, WYFI, MSTR, INTC. See the "Discussed alongside" section above for full asset pages.